Welcome to LookChem.com Sign In|Join Free
  • or
3-BENZYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

695811-96-2

Post Buying Request

695811-96-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

695811-96-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 695811-96-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,5,8,1 and 1 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 695811-96:
(8*6)+(7*9)+(6*5)+(5*8)+(4*1)+(3*1)+(2*9)+(1*6)=212
212 % 10 = 2
So 695811-96-2 is a valid CAS Registry Number.

695811-96-2Downstream Products

695811-96-2Relevant academic research and scientific papers

A de novo synthetic method to the access of N-substituted benzazepines

Ouchakour, Lamiaa,Nonn, Melinda,D'hooghe, Matthias,Kiss, Loránd

supporting information, (2020/02/04)

A novel, convenient procedure has been described for the construction of fluorine-containing benzazepines. The synthetic protocol starting from readily available dihydronaphthalene regioisomers is based on oxidative ring olefin bond cleavage followed by r

Tetrahydrobenzazepines and their use

-

Page/Page column 12, (2008/06/13)

The invention relates to tetrahydrobenzazepines of the general formula I in which the variables Ar, A, B, Y, R1 and R2 have the meaninigs indicated in claim 1, as well as the N-oxides of these compounds, the physiologically tolerated acid addition salts of these compounds and the physiologically tolerated acid addition salts of the N-oxides. The invention also relates to a pharmaceutical compositon that comprises at least one tetrahydrobenzazepine compound of the formula I, the physically tolerated acid addition salt of I, the N-oxide of compound of the formula I and/or the physically tolerated acid addition salts of the N-oxides of I, and further to the use of a compound according to the present invention for treating disorders that respond benefically to dopamine D3 receptor antagonists or dopamine D3 agonists. The compounds according to the invention are preferably useful for the treatment of disorders of the central nervous system such as schizophrenia and depression and for the treatment of renal function disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 695811-96-2